EXMceuticals is a dynamic company poised for success. Our team is composed of preeminent scientists in analytic and organic chemistry, molecular biology and biotechnology for its extraction and formulation operations. They work collaboratively to enhance EXM’s business performance and growth. Meet some of the key members of EXMceuticals’ executive team:
CEO and Chairman of the board
Mr Summers is a founding partner of a $500mn (USD) London based Investment fund. Before founding the Investment fund in 2015, Jonathan acted as a founder and senior executive in a major Hong Kong based asset management firm. Prior to that he was employed by Goldman Sachs for more than 15 years, in both London and Tokyo. His expertise in international business, acquaintance with multi-jurisdictional issues, and a management style based on best practices will contribute to further implement the Company’s global growth strategy.
Mr. Bernier has over 20 years of experience in project development, project implementation, and market development. He has been the lead advisor to several sovereign entities to negotiate and obtain Moody’s and Fitch credit ratings, bond issuance for sovereign infrastructure projects and the creation of SPV’s to fund and operate sovereign-owned infrastructure companies. Over this time, Mr. Bernier acquired a wide range of experience in the development and operation of private, public and sovereign large-scale projects.
Mr. Doyon is a senior partner at the JoliCoeur Lacasse law firm where he works in the business and taxation departments. He regularly provides support to entrepreneurs in their current operations and projects. Mr. Doyon also negotiates and acts on their behalf with government agencies to obtain required project authorizations.
After graduating from the University of Oslo with a Master of Law, Mr. Borch initially worked in private banking for DnB NOR, followed by positions focusing on tax and competition issues. He subsequently became a judge for two years prior to being appointed head of the legal department in Norske Skogindustrier ASA, specializing in mergers and acquisitions. In recent years, Mr. Borsh has continued these activities as a private practitioner in his own firm and sits on the boards of several private investment companies.
Chief Operating Officer
Mr. Amin is a senior finance and operations professional with over 15 years of international work experience spanning investment banking, international development, emerging markets private equity, business development and start-up operations. Demonstrated ability to successfully lead & manage M&A and capital raising (private and public) transactions and start & manage new functions and business lines (finance, accounting, strategy) with a focus on delivering strong results.
Mr. Amin has spent most of his career in investment banking at Merrill Lynch & Co. and Jefferies International, where he executed over $20bn in M&A transactions and associated equity and debt financings for various companies across a wide range of industries including Healthcare, Technology & Telecommunications, Industrials, Energy & Power and Food & Beverage. Most recently, he spent four years in Africa starting up and commercializing an agricultural manufacturing company involved in tropical fruit production and export to the EU and South Asia markets. He holds an BA in Economics from The University of Michigan – Ann Arbor and an MBA with a concentration in Finance and Accounting from The Wharton School at the University of Pennsylvania.
Chief Financial Officer
Mr. Kinley, a former partner with KPMG, has been the President of Winslow Associates Management & Communications Inc.since 1993, a private consulting firm which provides professional services to junior public companies. Mr. Kinley is a Chartered Professional Account and has served as an officer and director for several public companies over the past thirty years
Chief Executive Officer and Country Director Portugal
Mr. Martins has over 20 years of experience working in management, project development and project implementation, besides law and compliance affairs. He is a corporate and business lawyer specialized in project management, corporate finance, mergers & acquisitions, licensing and companies general management. He was the company secretary of a Portuguese public listed company, with extensive experience working in large multinational Portuguese and foreign companies on the construction (metallic construction & civil construction), energy (Eolic, biofuels, solar), real estate, telecoms and signalling (railroads), defence, software and start-ups.
He has a Degree in Law, with Postgraduate Studies in Law and Management, Securities Law, Territorial, Urban and Environmental Planning.
VP North American Operations
Mrs. Lemieux has over 20 years of experience in business, assisting large and small corporations across Canada to attain new levels of success and implement sustainable organizational changes. She has facilitated the reorganization of operational processes to improve efficiency and align strategic priorities for major oil and gas companies, environmental and engineering firms, governments, indigenous groups and national organizations. Her technological background will keep EXMceuticals on the front of technologies and innovative ways of doing business. Mrs. Lemieux has led various and large multidisciplinary teams situated around the world with incredible success. She is often asked to do the impossible and strives to recover lost situations for businesses. She is particularly interested in continuous improvement. She always finds solutions. She is an ex-ski racer and represents Canada on many committees at the International Ski Federation.
Adilia Januário Charmier
VP Research and Development
Mrs. Charmier obtained a Ph.D. in Organic Chemistry and a Master of Science in Chemistry from the Université Blaise Pascal in France. She is a Professor as well as Director of the Biotechnological Engineering department and the postgraduate courses in Circular Economy at Universidade Lusófona (ULHT) in Lisbon, Portugal. Her main scientific areas of interest and expertise are: organic ligands reactivity, metal-mediated organic synthesis, coordination chemistry, cycloaddition reactions, catalysis, heterocycles, microwave-assisted-promoted synthesis, biocatalysis, biopolymers, bio-based materials, extraction of plants and fruits, valorization of olive, beer and wine wastes using green technologies, study of the biological properties of extracts (antimicrobial, anti-tumoral, antioxidant activities) and their application in health (hospital infections, neurodegenerative diseases) and food. Mrs. Charmier has published over 25 scientific papers, has been a speaker at 35 scientific conferences, and she holds 3 patents.
Director Science & Genetics
Mrs. Santos majored in Genetics and Microbiology at Lisbon’s Faculty of Sciences. Susana holds a PhD in Molecular Biology (Lisbon’s Faculty of Sciences) as well as a Post-Doc in Molecular Biology (Lisbon´s Faculty of Pharmacy). As a researcher of Lisbon´s Faculty of Pharmacy and Lisbon´s Instituto Superior Técnico, she has coordinated a national project (Cardiogenetics) and participated in more than 10 national projects (Cardiogenetics and Cancer). In 2009 she became Assistant Professor at Universidade Lusófona de Humanidades e Tecnologias of several subjects related to Genetics, Molecular Biology, Forensics and Biotechnology. She published about 14 scientific papers and 1 book chapter. In 2013, she became a co-founder of the start-up HeartGenetics, Genetics and Biotechnology a company that pioneers a methodology that integrates Genomics and Computational Technologies for innovative knowledge that supports healthcare providers to promote wellness, prevent illness and diagnose diseases. She was Chief of Technology Officer and Director of Quality Management System. She was responsible for the implementation and maintenance of the Quality Management System ISO 9001 and ISO13485. She developed genetic tests with applications in cardiovascular diseases, pharmacogenetics, cardio-oncology, nutrigenetics, and athletic performance. Susana focuses on biotechnology strategies for therapeutical and wellness purposes and in the evaluation of phytochemicals with potential therapeutic usage.
Mr. Touja holds a diploma in Microbiology & AgroSciences from the University of Toulouse, a master’s in Microbiology from the University of Toulouse and a Master in Nutraceutical Engineering from the Rennes University. He is an experienced R&D and Production Manager who has worked on large scale production and R&;D projects related to nutraceuticals and natural product-based medical products.